Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.
Maria ReigPeter Robert GalleMasatoshi KudoRichard S FinnJosep M LlovetAndrea L RossoWilliam R SchelmanKun LiangChunxiao WangRyan C WidauPaolo AbadaAndrew X ZhuPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
The emergence of new extrahepatic lesions in the second-line setting is a poor prognostic factor for post-progression survival. The benefit of ramucirumab for overall survival was consistent across progression patterns.
Keyphrases